UNSPSC 51422405: Ciclesonide

This classification denotes a therapeutic glucocorticoid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S59502J185. European Medicines Agency schedules Ciclesonide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06236MIG. Ciclesonide generally arises in the molecular formula C32H44O7. The term CICLESONIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, no. 3 1990, list 30.) Most nations schedule ciclesonide under HS 29372900 and SITC 54153.

As of Q4 2014, CICLESONIDE remains the US FDA Preferred Term for this commodity. Ciclesonide bears US NLM identifiers UMLS ID C0907850 and NCI Concept Code C65326. SMILES: O1C2(C3(C(C4C(C(O)C3)C3(C(=CC(=O)C=C3)CC4)C)CC2OC1C1CCCCC1)C)C(=O)COC(=O)C(C)C.

UNSPSC 51422405 Ciclesonide, a Commodity code, covers pharmaceutical products procured by state and local health and human services agencies, though recent activity under this specific code does not reflect direct ciclesonide procurement. The Seminole County, Florida opportunity (IFB 60459723LAS, posted June 30, 2026, due July 26, 2023) solicited naloxone and drug deactivation systems rather than ciclesonide, and the Texas Health and Human Services Commission RFI (HHS0017013, posted April 3, 2026) focused on direct-to-manufacturer prescription programs and pharmacy benefit management rather than a named pharmaceutical product. The code appears to index pharmaceutical commodities broadly, but the recent state and local opportunities captured under it do not align with ciclesonide's nominal scope—a mismatch suggesting either miscategorization in source records or low current demand signaling for this specific pharmaceutical.

The geographic activity visible under this code is limited to Florida and Texas, with no other states represented in the recent opportunities block. Issuing bodies include Seminole County (a county health department function) and the Texas Health and Human Services Commission (a state agency). No additional representative solicitations, repeat buyers, or meaningful geographic concentration emerge from the available source material. The absence of direct ciclesonide procurement in state and local opportunities currently tracked under this code warrants verification of whether demand exists before pursuing this commodity actively.